Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Original Research

Accepted on 30 May 2025

Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids

in Cardiovascular and Smooth Muscle Pharmacology

Siwen Fan
Hongxia Du
Siyu Li
Guangxu Xiao
Yuhan Zhao
Shuang He
Guanwei Fan
Yan Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491582

Review

Accepted on 30 May 2025

Efficacy of different dosages of common uric acid-lowering medications in gout patients: A network meta-analysis of randomized control trials

in Cardiovascular and Smooth Muscle Pharmacology

Xiaojia Zheng
Cunxiang Xie
Jinying Fang
Zhenhui Huang
Jian Huang
Luming Zhao
Guancheng Ye
Hailong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565530

Original Research

Accepted on 30 May 2025

Protective effect of salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis

in Cardiovascular and Smooth Muscle Pharmacology

Xing Ji
Kailin Huang
Aimei Lu
Xiaomeng Hu
Huanlin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548811

Original Research

Published on 30 May 2025

Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle

in Cardiovascular and Smooth Muscle Pharmacology

Renfeng Li
Jinkong Wu
Meizhu Wu
Farman Ali
Yanyan Yang
Hong Chen
Zhi Guo
Dawei Lian
Aling Shen
Jun Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573483

176 views

Original Research

Accepted on 29 May 2025

Gastrodin Mitigates Aortic Valve Calcification by Inhibiting Glycolysis and Histone Lactylation Through Interfering with Valve Interstitial Cells

in Cardiovascular and Smooth Muscle Pharmacology

Yu Zhang
Shunshun Wang
Jiaqin Wu
Qianqian Du
Huiming Yu
Li Yang
Xianqiong Liu
Kang Xu
Chunli Wang
Fan Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547716

Original Research

Accepted on 29 May 2025

Multicenter Retrospective Comparison of Safety and Efficacy Among Three Antithrombotic Regimens Following TAVI

in Cardiovascular and Smooth Muscle Pharmacology

Yu Ren
Jing Chen
Suchun Wang
Zhengli Jiang
Hua Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531361

Original Research

Published on 29 May 2025

Population pharmacokinetic analysis of rivaroxaban in healthy volunteers and patients with radiofrequency ablation of non-valvular atrial fibrillation in China

in Cardiovascular and Smooth Muscle Pharmacology

Fangfang Gu
Kaixian Tang
Cong Zhang
Mingsheng Hu
Junlong Sun
Xiang Yu
Mengli Tian
Chen Zhang
Yingrong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562259

344 views

Review

Accepted on 26 May 2025

Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension

in Cardiovascular and Smooth Muscle Pharmacology

Yimo Huang
Wende Ma
Cen Guo
Xiaoling Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596767

137 views

Review

Published on 26 May 2025

The biology of exosomes and exosomal non-coding RNAs in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Lu Gan
Xiaofei Guo
Shichao Dong
Chuan Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529375

273 views

Review

Published on 26 May 2025

Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes

in Cardiovascular and Smooth Muscle Pharmacology

Soroush Taherkhani
Mohammad Sheibani
Ali Mohammadkhanizadeh
Jitka A. I. Virag
Lisandra de Castro Braz
Yaser Azizi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559288

389 views

Correction

Accepted on 23 May 2025

Corrigendum: Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

in Cardiovascular and Smooth Muscle Pharmacology

Min Chen
Yingying Xiao
Jijian Zheng
Peibin Zhao
Lin Cheng
Chuan Jiang
Sixie Zheng
Zheng Wang
Sijuan Sun
Lincai Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1633008

Review

Published on 23 May 2025

Advances in the treatment of lower-extremity ischemia-reperfusion injury

in Cardiovascular and Smooth Muscle Pharmacology

Jin Peng
Tang Deng
Xunkai Wang
Jinxi Liang
Jiangpeng Wu
Binglong Li
Jun Lv
Shenmei Wu
Shijie Zhong
Chen Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576091

366 views

Original Research

Published on 21 May 2025

Adenosine deaminase mediates endothelial inflammation via an ADA1-CD26 interaction in post-COVID

in Cardiovascular and Smooth Muscle Pharmacology

Ada Kawecka
Klaudia Stawarska
Marzena Romanowska-Kocejko
Marta Żarczyńska-Buchowiecka
Agata Jędrzejewska
Alicja Braczko
Milena Deptuła
Małgorzata Zawrzykraj
Oliwia Król
Marika Frańczak

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578973

357 views

Review

Published on 21 May 2025

Multifunctional applications and research advances of low-molecular-weight heparin

in Cardiovascular and Smooth Muscle Pharmacology

Yanru Zhang
Shuixian Guo
Jingchao Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585762

444 views

Original Research

Published on 20 May 2025

Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats

in Cardiovascular and Smooth Muscle Pharmacology

Vivian Fuguhara
Mariana Gonçalves De Oliveira
Carlos Alberto Aguiar da Silva
Pedro Renato Guazzelli
Larryn W. Peterson
Gilberto De Nucci

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557997

471 views

Review

Published on 19 May 2025

Decoding glycosylation in cardiovascular diseases: mechanisms, biomarkers, and therapeutic opportunities

in Cardiovascular and Smooth Muscle Pharmacology

Gang Li
Kaidi Ren
Yage Jin
Yang Yang
Yi Luan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570158

290 views